Allergan Receives FDA Qualified Infectious Disease Product (QIDP) Designation And Fast Track Designation For ATM-AVI (Aztreonam And Avibactam) For Antibiotic-Resistant Gram-Negative Infections

FDA QIDP and Fast Track Designations Signify Significant Milestones in Allergan Commitment to Addressing Unmet Medical Needs in the Treatment of Antibiotic Resistant InfectionsDUBLIN, Nov. 11, 2019 -- (Healthcare Sales & Marketing Network)-- Allergan...Biopharmaceuticals, FDA
Allergan, ATM-AVI, aztreonam, avibactam